Small RNA and transcriptional upregulation

Advanced Review

Victoria Portnoy, Vera Huang, Robert F. Place, Long‐Cheng Li

Published Online: May 02 2011

DOI: 10.1002/wrna.90

Full article on Wiley Online Library: HTML PDF

Can't access this content? Tell your librarian.

Small RNA molecules, such as microRNA and small interfering RNA, have emerged as master regulators of gene expression through their ability to suppress target genes in a phenomenon collectively called RNA interference (RNAi). There is growing evidence that small RNAs can also serve as activators of gene expression by targeting gene regulatory sequences. This novel mechanism, known as RNA activation (RNAa), appears to be conserved in at least mammalian cells and triggered by both endogenous and artificially designed small RNAs. RNAa depends on Argonaute proteins, but possesses kinetics distinct from that of RNAi. Epigenetic changes are associated with RNAa and may contribute to transcriptional activation of target genes, but the underlying mechanism remains elusive. Given the potential of RNAa as a molecular tool for studying gene function and as a therapeutic for disease, further research is needed to completely elucidate its molecular mechanism in order to refine the rules for target selection and improve strategies for exploiting it therapeutically. WIREs RNA 2011 2 748–760 DOI: 10.1002/wrna.90

This WIREs title offers downloadable PowerPoint presentations of figures for non-profit, educational use, provided the content is not modified and full credit is given to the author and publication.

Download a PowerPoint presentation of all images

Figure 1.

Whole‐genome promoter microRNA (miRNA) target prediction. (a) Histogram depicting the number of promoters (1 kb) in the human genome versus the number of sites predicted to be complementary to known human miRNAs. (b) The number of miRNA hits in gene promoters positively correlates to the GC content of miRNAs. Shown is a semi‐log plot with the number of promoter hits in logarithmic scale on the y‐axis and GC content (GC%) of miRNAs in linear scale on the x‐axis.

[ Normal View | Magnified View ]

Figure 2.

Mechanism for RNA activation. An exogenously introduced or naturally occurring saRNA/agRNA is loaded into an Ago protein (e.g., Ago2) where the passenger strand is cleaved and discarded, resulting in an active Ago–RNA complex. This complex gains access to the nuclear compartment by either passive transport when the nuclear envelope disappears during mitosis or active transport mechanisms. The complex may then bind to (a) complementary DNA sequences or (b) nascent cognate transcripts in promoters or 3′ flanking regions and further recruit histone modifiers, leading to an open chromatin structure and active transcription. Ago, Argonaut proteins; agRNA, antigene RNA; ncRNA, noncoding RNA; saRNA, small activating RNA.

[ Normal View | Magnified View ]

References

Fire, A, Xu, S, Montgomery, MK, Kostas, SA, Driver, SE, Mello, CC. Potent and specific genetic interference by double‐stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806–811.
Elbashir, SM, Harborth, J, Lendeckel, W, Yalcin, A, Weber, K, Tuschl, T. Duplexes of 21‐nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494–498.
Morris, KV, Chan, SW, Jacobsen, SE, Looney, DJ. Small interfering RNA‐induced transcriptional gene silencing in human cells. Science 2004, 305:1289–1292.
Volpe, TA, Kidner, C, Hall, IM, Teng, G, Grewal, SI, Martienssen, RA. Regulation of heterochromatic silencing and histone H3 lysine‐9 methylation by RNAi. Science 2002, 297:1833–1837.
Olsen, PH, Ambros, V. The lin‐4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN‐14 protein synthesis after the initiation of translation. Dev Biol 1999, 216:671–680.
Bagga, S, Bracht, J, Hunter, S, Massirer, K, Holtz, J, Eachus, R, Pasquinelli, AE. Regulation by let‐7 and lin‐4 miRNAs results in target mRNA degradation. Cell 2005, 122:553–563.
Li, LC, Okino, ST, Zhao, H, Pookot, D, Place, RF, Urakami, S, Enokida, H, Dahiya, R. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A 2006, 103:17337–17342.
Janowski, BA, Younger, ST, Hardy, DB, Ram, R, Huffman, KE, Corey, DR. Activating gene expression in mammalian cells with promoter‐targeted duplex RNAs. Nat Chem Biol 2007, 3:166–173.
Place, RF, Li, LC, Pookot, D, Noonan, EJ, Dahiya, R. MicroRNA‐373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 2008, 105:1608–1613.
Turunen, MP, Lehtola, T, Heinonen, SE, Assefa, GS, Korpisalo, P, Girnary, R, Glass, CK, Vaisanen, S, Yla‐Herttuala, S. Efficient regulation of VEGF expression by promoter‐targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy. Circ Res 2009, 105:604–609.
Huang, V, Qin, Y, Wang, J, Wang, X, Place, RF, Lin, G, Lue, TF, Li, LC. RNAa is conserved in mammalian cells. PLoS ONE 2010, 5:e8848.
Wassenegger, M, Heimes, S, Riedel, L, Sanger, HL. RNA‐directed de novo methylation of genomic sequences in plants. Cell 1994, 76:567–576.
Graff, JR, Herman, JG, Lapidus, RG, Chopra, H, Xu, R, Jarrard, DF, Isaacs, WB, Pitha, PM, Davidson, NE, Baylin, SB. E‐cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995, 55:5195–5199.
Li, LC, Zhao, H, Nakajima, K, Oh, BR, Filho, LA, Carroll, P, Dahiya, R. Methylation of the E‐cadherin gene promoter correlates with progression of prostate cancer. J Urol 2001, 166:705–709.
Reynolds, A, Leake, D, Boese, Q, Scaringe, S, Marshall, WS, Khvorova, A. Rational siRNA design for RNA interference. Nat Biotechnol 2004, 22:326–330.
Mao, Q, Li, Y, Zheng, X, Yang, K, Shen, H, Qin, J, Bai, Y, Kong, D, Jia, X, Xie, L. Up‐regulation of E‐cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells. Biochem Biophys Res Commun 2008, 375:566–570.
Mao, Q, Zheng, X, Yang, K, Qin, J, Bai, Y, Jia, X, Li, Y, Xie, L. Suppression of migration and invasion of PC3 prostate cancer cell line via activating E‐cadherin expression by small activating RNA. Cancer Invest 2010, 28:1013–1018.
Junxia, W, Ping, G, Yuan, H, Lijun, Z, Jihong, R, Fang, L, Min, L, Xi, W, Ting, H, Ke, D, et, al. Double strand RNA‐guided endogeneous E‐cadherin up‐regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo. Cancer Sci 2010, 101:1790–1796.
Chen, Z, Place, RF, Jia, ZJ, Pookot, D, Dahiya, R, Li, LC. Antitumor effect of dsRNA‐induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther 2008, 7:698–703.
Yang, K, Zheng, XY, Qin, J, Wang, YB, Bai, Y, Mao, QQ, Wan, Q, Wu, ZM, Xie, LP. Up‐regulation of p21(WAF1/Cip1) by saRNA induces G1‐phase arrest and apoptosis in T24 human bladder cancer cells. Cancer Lett 2008, 265:206–214.
Wei, J, Zhao, J, Long, M, Han, Y, Wang, X, Lin, F, Ren, J, He, T, Zhang, H. p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell. BMC Cancer 2010, 10:632.
Whitson, JM, Noonan, EJ, Pookot, D, Place, RF, Dahiya, R. Double stranded‐RNA‐mediated activation of P21 gene induced apoptosis and cell cycle arrest in renal cell carcinoma. Int J Cancer 2009, 125:446–452.
Wang, J, Place, RF, Huang, V, Wang, X, Noonan, EJ, Magyar, CE, Huang, J, Li, LC. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector‐mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res 2010, 70:10182–10191.
Matsui, M, Sakurai, F, Elbashir, S, Foster, DJ, Manoharan, M, Corey, DR. Activation of LDL receptor expression by small RNAs complementary to a noncoding transcript that overlaps the LDLR promoter. Chem Biol 2010, 17:1344–1355.
Schwartz, JC, Younger, ST, Nguyen, NB, Hardy, DB, Monia, BP, Corey, DR, Janowski, BA. Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol 2008, 15:842–848.
Yue, X, Schwartz, JC, Chu, Y, Younger, ST, Gagnon, KT, Elbashir, S, Janowski, BA, Corey, DR. Transcriptional regulation by small RNAs at sequences downstream from 3′ gene termini. Nat Chem Biol 2010, 6:621–629.
Yin, H, Lin, H. An epigenetic activation role of Piwi and a Piwi‐associated piRNA in Drosophila melanogaster. Nature 2007, 450:304–308.
Vasudevan, S, Steitz, JA. AU‐rich‐element‐mediated upregulation of translation by FXR1 and Argonaute 2. Cell 2007, 128:1105–1118.
Vasudevan, S, Tong, Y, Steitz, JA. Switching from repression to activation: microRNAs can up‐regulate translation. Science (New York, NY) 2007, 318:1931–1934.
Petrascheck, M, Escher, D, Mahmoudi, T, Verrijzer, CP, Schaffner, W, Barberis, A. DNA looping induced by a transcriptional enhancer in vivo. Nucleic Acids Res 2010, 33:3743–3750.
Dykxhoorn, DM, Novina, CD, Sharp, PA. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003, 4:457–467.
Place, RF, Noonan, EJ, Foldes‐Papp, Z, Li, LC. Defining features and exploring chemical modifications to manipulate RNAa activity. Curr Pharm Biotechnol 2010, 11:518–526.
Novina, CD, Sharp, PA. The RNAi revolution. Nature 2010, 430:161–164.
Han, J, Kim, D, Morris, KV. Promoter‐associated RNA is required for RNA‐directed transcriptional gene silencing in human cells. Proc Natl Acad Sci U S A 2007, 104:12422–12427.
Mahmoudi, S, Henriksson, S, Corcoran, M, Mendez‐Vidal, C, Wiman, KG, Farnebo, M. Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol Cell 2009, 33:462–471.
Gonzalez, S, Pisano, DG, Serrano, M. Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs. Cell Cycle 2008, 7:2601–2608.
Carninci, P, Kasukawa, T, Katayama, S, Gough, J, Frith, MC, Maeda, N, Oyama, R, Ravasi, T, Lenhard, B, Wells, C, et al. The transcriptional landscape of the mammalian genome. Science 2010, 309:1559–1563.
Katayama, S, Tomaru, Y, Kasukawa, T, Waki, K, Nakanishi, M, Nakamura, M, Nishida, H, Yap, CC, Suzuki, M, Kawai, J, et al. Antisense transcription in the mammalian transcriptome. Science 2010, 309:1564–1566.
Taft, RJ, Glazov, EA, Cloonan, N, Simons, C, Stephen, S, Faulkner, GJ, Lassmann, T, Forrest, AR, Grimmond, SM, Schroder, K, et al. Tiny RNAs associated with transcription start sites in animals. Nat Genet 2009, 41:572–578.
Goodrich, JA, Kugel, JF. From bacteria to humans, chromatin to elongation, and activation to repression: the expanding roles of noncoding RNAs in regulating transcription. Crit Rev Biochem Mol Biol 2009, 44:3–15.
Katayama, S, Tomaru, Y, Kasukawa, T, Waki, K, Nakanishi, M, Nakamura, M, Nishida, H, Yap, CC, Suzuki, M, Kawai, J, et al. Antisense transcription in the mammalian transcriptome. Science 2005, 309:1564–1566.
Chu, Y, Yue, X, Younger, ST, Janowski, BA, Corey, DR. Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non‐coding transcript at the progesterone receptor promoter. Nucleic Acids Res 2010, 38:7736–7748.
Bekhor, I, Bonner, J, Dahmus, GK. Hybridization of chromosomal RNA to native DNA. Proc Natl Acad Sci U S A 1969, 62:271–277.
Frenster, JH. Selective control of DNA helix openings during gene regulation. Cancer Res 1976, 36(9 PT 2): 3394–3398.
Roberts, RW, Crothers, DM. Stability and properties of double and triple helices: dramatic effects of RNA or DNA backbone composition. Science 1992, 258: 1463–1466.
Pelissier, T, Thalmeir, S, Kempe, D, Sanger, HL, Wassenegger, M. Heavy de novo methylation at symmetrical and non‐symmetrical sites is a hallmark of RNA‐directed DNA methylation. Nucleic Acids Res 1999, 27: 1625–1634.
Matzke, M, Aufsatz, W, Kanno, T, Daxinger, L, Papp, I, Mette, MF, Matzke, AJ. Genetic analysis of RNA‐mediated transcriptional gene silencing. Biochim Biophys Acta 2004, 1677:129–141.
Tsai, MC, Manor, O, Wan, Y, Mosammaparast, N, Wang, JK, Lan, F, Shi, Y, Segal, E, Chang, HY. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689–693.
Gilbert, SL, Pehrson, JR, Sharp, PA. XIST RNA associates with specific regions of the inactive X chromatin. J Biol Chem 2000, 275:36491–36494.
Liu, J, Carmell, MA, Rivas, FV, Marsden, CG, Thomson, JM, Song, JJ, Hammond, SM, Joshua‐Tor, L, Hannon, GJ. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004, 305:1437–1441.
Janowski, BA, Huffman, KE, Schwartz, JC, Ram, R, Nordsell, R, Shames, DS, Minna, JD, Corey, DR. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol 2006, 13:787–792.
Kim, DH, Villeneuve, LM, Morris, KV, Rossi, JJ. Argonaute‐1 directs siRNA‐mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol 2006, 13:793–797.
Rand, TA, Petersen, S, Du, F, Wang, X. Argonaute2 cleaves the anti‐guide strand of siRNA during RISC activation. Cell 2005, 123:621–629.
Matranga, C, Tomari, Y, Shin, C, Bartel, DP, Zamore, PD. Passenger‐strand cleavage facilitates assembly of siRNA into Ago2‐containing RNAi enzyme complexes. Cell 2005, 123:607–620.
Ohrt, T, Mutze, J, Staroske, W, Weinmann, L, Hock, J, Crell, K, Meister, G, Schwille, P. Fluorescence correlation spectroscopy and fluorescence cross‐correlation spectroscopy reveal the cytoplasmic origination of loaded nuclear RISC in vivo in human cells. Nucleic Acids Res 2008, 36:6439–6449.
Rudel, S, Flatley, A, Weinmann, L, Kremmer, E, Meister, G. A multifunctional human Argonaute2‐specific monoclonal antibody. RNA (New York, NY) 2008, 14: 1244–1253.
Tan, GS, Garchow, BG, Liu, X, Yeung, J, Morris JPt, Cuellar, TL, McManus, MT, Kiriakidou, M. Expanded RNA‐binding activities of mammalian Argonaute 2. Nucleic Acids Res 2009, 37:7533–7545.
Jopling, CL, Yi, M, Lancaster, AM, Lemon, SM, Sarnow, P. Modulation of hepatitis C virus RNA abundance by a liver‐specific MicroRNA. Science 2005, 309: 1577–1581.
Orom, UA, Nielsen, FC, Lund, AH. MicroRNA‐10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008, 30:460–471.
Saito, T, Saetrom, P. MicroRNAs—targeting and target prediction. N Biotechnol 2010, 27:243–249.
Zhang, Y, Verbeek, FJ. Comparison and Integration of target prediction algorithms for microRNA studies. J Integr Bioinform 2010, 7:1–13.
Kim, DH, Saetrom, P, Snove, O Jr, Rossi JJ. MicroRNA‐directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A 2008, 105: 16230–16235.
Younger, ST, Pertsemlidis, A, Corey, DR. Predicting potential miRNA target sites within gene promoters. Bioorg Med Chem Lett 2009, 19:3791–3794.
Enright, AJ, John, B, Gaul, U, Tuschl, T, Sander, C, Marks, DS. MicroRNA targets in Drosophila. Genome Biol 2003, 5:R1.
Antequera, F. Structure, function and evolution of CpG island promoters. Cell Mol Life Sci 2003, 60: 1647–1658.
Vagin, VV, Sigova, A, Li, C, Seitz, H, Gvozdev, V, Zamore, PD. A distinct small RNA pathway silences selfish genetic elements in the germline. Science 2006, 313: 320–324.
Lau, NC, Seto, AG, Kim, J, Kuramochi‐Miyagawa, S, Nakano, T, Bartel, DP, Kingston, RE. Characterization of the piRNA complex from rat testes. Science 2006, 313:363–367.
Grivna, ST, Beyret, E, Wang, Z, Lin, H. A novel class of small RNAs in mouse spermatogenic cells. Genes Dev 2006, 20:1709–1714.
Aravin, A, Gaidatzis, D, Pfeffer, S, Lagos‐Quintana, M, Landgraf, P, Lovino, N, Morris, P, Brownstein, MJ, Kuramochi‐Miyagawa, S, Nakano, T, et al. A novel class of small RNAs bind to MILI protein in mouse testes. Nature 2006, 442:203–207.
Hwang, HW, Wentzel, EA, Mendell, JT. A hexanucleotide element directs microRNA nuclear import. Science 2007, 315:97–100.
Liao, JY, Ma, LM, Guo, YH, Zhang, YC, Zhou, H, Shao, P, Chen, YQ, Qu, LH. Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3′ trailers. PLoS ONE 2010, 5:e10563.
Ohrt, T, Merkle, D, Birkenfeld, K, Echeverri, CJ, Schwille, P. In situ fluorescence analysis demonstrates active siRNA exclusion from the nucleus by Exportin 5. Nucleic Acids Res 2006, 34:1369–1380.
Brinster, RL, Allen, JM, Behringer, RR, Gelinas, RE, Palmiter, RD. Introns increase transcriptional efficiency in transgenic mice. Proc Natl Acad Sci U S A 1988, 85: 836–840.
Clark, AJ, Archibald, AL, McClenaghan, M, Simons, JP, Wallace, R, Whitelaw, CB. Enhancing the efficiency of transgene expression. Philos Trans R Soc Lond B Biol Sci 1993, 339:225–232.
Stemmler, MP, Hecht, A, Kemler, R. E‐cadherin intron 2 contains cis‐regulatory elements essential for gene expression. Development 2005, 132:965–976.
Breitbart, RE, Nguyen, HT, Medford, RM, Destree, AT, Mahdavi, V, Nadal‐Ginard, B. Intricate combinatorial patterns of exon splicing generate multiple regulated troponin T isoforms from a single gene. Cell 1985, 41: 67–82.
Leff, SE, Rosenfeld, MG, Evans, RM. Complex transcriptional units: diversity in gene expression by alternative RNA processing. Annu Rev Biochem 1986, 55: 1091–1117.
Aigner, A. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J Biotechnol 2006, 124:12–25.
Frixen, UH, Behrens, J, Sachs, M, Eberle, G, Voss, B, Warda, A, Lochner, D, Birchmeier, W. E‐cadherin‐mediated cell‐cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991, 113:173–185.
Richards, FM, McKee, SA, Rajpar, MH, Cole, TR, Evans, DG, Jankowski, JA, McKeown, C, Sanders, DS, Maher, ER. Germline E‐cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 1999, 8:607–610.
Fang, L, Igarashi, M, Leung, J, Sugrue, MM, Lee, SW, Aaronson, SA. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 1999, 18:2789–2797.
Watts, JK, Yu, D, Charisse, K, Montaillier, C, Potier, P, Manoharan, M, Corey, DR. Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non‐coding transcripts at gene promoters. Nucleic Acids Res 2010, 38:5242–5259.